NIAID to Fund Research into Vector-Host Interactions | GenomeWeb

NEW YORK (GenomeWeb) – The National Institute of Allergy and Infectious Diseases plans to fund research focused on better understanding the biology and immunology of natural viral infections and HIV vaccine vectors, including studies that will use a wide range of omics approaches.

NIAID said in a funding announcement on Friday it will support R01 research project grants for five years, and it will fund R21 exploratory or development projects with up to $275,000 over two years to pursue these studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.